Enno Spillner

Director of Finance/CFO at FORMYCON AG

Net worth: 158 892 $ as of 2026-05-30

57 year

41 connections

Finance

Health Technology

Commercial Services

Profile

Presently, Enno Spillner holds the position of Chief Financial Officer for Evotec SE and Co-Managing Director at Evotec International GmbH (a subsidiary of Evotec SE). He is also on the board of Nanobiotix SA and Concentro Management AG and Managing Partner at Biom Venture Capital GmbH & Co. Fonds KG. In his past career Mr. Spillner occupied the position of Chief Executive & Financial Officer of 4SC AG, Managing Director at Munich Innovative Biomaterials GmbH, Managing Director at ActiPac Biosystems GmbH and Head-Finance & Controlling at BioM AG Munich BioTech Development. Enno Spillner received an MBA from the University of Bamberg.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NANOBIOTIX SA 0.01%	2026-03-30	4,000 ( 0.01% )	158 892 $	2026-05-30

Enno Spillner active positions

Companies	Position	Start
NANOBIOTIX	Director/Board Member	2014-06-17
FORMYCON AG	Director of Finance/CFO	2023-03-31
Concentro Management AG Concentro Management AG Investment ManagersFinance Provides financial consulting services	Director/Board Member	2010-05-10
leon-nanodrugs GmbH leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing	Director/Board Member	-
Euronext Paris SA Euronext Paris SA Investment Banks/BrokersFinance Operates a stock exchange which provides solutions for regulated stock and derivatives markets in France	Director/Board Member	2013-12-31

All active positions of Enno Spillner

Former positions of Enno Spillner

Companies	Position	End
EVOTEC SE	Director of Finance/CFO	2023-02-28
4SC AG	Chief Executive Officer	2016-06-29
ActiPac Biosystems GmbH	Chief Executive Officer	2000-02-29
Munich Innovative Biomaterials GmbH Munich Innovative Biomaterials GmbH Investment ManagersFinance Functions as a pension/retirement fund	Chief Executive Officer	-
░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░ ░░░░░░░░░ ░░░░░░░	-

See the detail of Enno Spillner's experience

Training of Enno Spillner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Enno Spillner's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
4SC AG 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment	Health Technology
Evotec SE Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services	Commercial Services
Evotec International GmbH Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Develops and provides drugs specializing in the treatment of CNS disorders	Commercial Services
Euronext Paris SA Euronext Paris SA Investment Banks/BrokersFinance Operates a stock exchange which provides solutions for regulated stock and derivatives markets in France	Finance
BioM AG Munich BioTech Development BioM AG Munich BioTech Development Investment ManagersFinance BMBD is a venture capital investment manager specialized in early-stage biotechnology companies with high-growth potential. The firm invests in Europe with a strong focus on the Munich area. They generally co-invest, often in companies first launched through a seed investment from BioM. BMBD generally acquires minority stakes. Their goal is to accompany their portfolio companies into the later stages of development. In addition to capital, the firm provides business support services leveraging BioM's network and capabilities.	Finance
University of Bamberg University of Bamberg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Biom Venture Capital GmbH & Co. Fonds KG Biom Venture Capital GmbH & Co. Fonds KG Investment ManagersFinance Acts as Venture Capital Fund	Finance
Nanobiotix SA Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer	Health Technology
Concentro Management AG Concentro Management AG Investment ManagersFinance Provides financial consulting services	Finance
Formycon AG Formycon AG Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products	Health Technology
leon-nanodrugs GmbH leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing	Technology Services
ActiPac Biosystems GmbH
Munich Innovative Biomaterials GmbH Munich Innovative Biomaterials GmbH Investment ManagersFinance Functions as a pension/retirement fund	Finance